This page lists all known medications that could potentially lead to 'Neurofibroma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Healx has secured the US Food and Drug Administration (FDA) clearance for an investigational new drug application (IND) to commence a Phase II clinical trial of HLX-1502, targeting adults with ...

Neurogenic tumour of the nasal cavity is a rare entity and it is rarer still for it to present with visual problem. We like to report a rare case of solitary nasal neurofibroma, which came to light ...

CHICAGO -- Selumetinib (Koselugo) significantly improved response rates in adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas, the phase III KOMET trial ...

Erratum: Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: ...

Effective medical therapies are lacking for the treatment of neurofibromatosis type 1–related plexiform neurofibromas, which are characterized by elevated RAS–mitogen-activated protein kinase (MAPK) ...

Neurofibromatosis Type 1 (NF1) is an autosomal dominant disorder that commonly presents with ophthalmic lesions. 1 We would like to present a case of a patient with previously undiagnosed NF1 ...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Plexiform Neurofibroma Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035" has been added to ResearchAndMarkets.com's ...

Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder ...

In conclusion, isolated enteric neurofibroma-associated long-tract intussusception is rare. Abdominal CT is clinically important for the diagnosis, but the final diagnosis depends on postoperative ...

Surgeons at Korea University Anam Hospital have offered pro bono surgery to a 30-year-old neurofibroma patient named Rasoanandrasana Vaosolo from the Republic of Madagascar, the hospital said Thursday ...

Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses ...